Search Results for "Asahi Kasei A Bpep"

06:48 EDT 20th August 2014 | BioPortfolio

Matching Channels


Matching News

Asahi Kasei Corporation: Company Profile and SWOT Analysis

Recently added to the BioPortfolio report store, Asahi Kasei Corporation: Company Profile and SWOT Analysis is a new report from ICD Research published on 2011-09-09. This 35-page report is availabl...

RaQualia and Asahi Kasei Pharma progress their collaboration

RaQualia Pharma says that its ongoing joint research with fellow Japanese drugmaker Asahi Kasei Pharma has moved to a new phase. Following the positive results from the collaborative research under th...

Asahi Kasei Zoll Medical obtains Japanese approval for R Series Monitor/Defibrillator

Asahi Kasei Zoll Medical (AZM), the Japanese subsidiary of Zoll Medical, has obtained Shonin approval from the Japanese Ministry of Health, Labour and Welfare for its R Series Monitor/Defibrillator.

US Court upholds damages award in Actelion/Asahi litigation

Switzerland-based Actelion says that the California Supreme Court has denied the firm’ petition for review of the Court of Appeal's decision affirming the final judgment entered against Actelion in...

Actelion, Asahi Kasei Pharma, Washington Legal Foundation cardiovascular news

Zoll Receives Shonin Approval from Japanese Ministry of Health, Labour and Welfare to Market the R Series Monitor/Defibrillator

ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that its Japanese subsidiary, Asahi Kasei ZOLL Medical (AZM), has recei...

Roughly 90% Of Large Japanese Companies Extend Care Leave: Asahi Survey

With the turnover of nursing and care employees being 100,000 per year in Japan, roughly 90% of large companies in the country are extending nursing leave to a period longer than that required by law,...

ASAHI INTECC, Boston Scientific to develop new, differentiated FFR wire

Boston Scientific Corporation and ASAHI INTECC (Securities Code 7747, Second Section, Tokyo and Nagoya Stock Exchange) have formalized plans to develop a new, differentiated fractional flow reserve (F...

Matching PubMed Articles

Intravitreal fasudil combined with bevacizumab for treatment of refractory diabetic macular edema; a pilot study.

To evaluate the effect of intravitreal injection of a Rho-associated protein kinase (ROCK) inhibitor (Fasudil, Asahi Kasei Pharma Corporation, Tokyo, Japan) combined with intravitreal bevacizumab (IVB...

Search Whole site using Google

Search BioPortfolio:
Advertisement Advertisement